ORIC Pharmaceuticals, Inc. (ORIC)

ORIC Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	75.86	59.41	23.38	66.84	226.01	78.45
Short-Term Investments	206.65	196.55	184.8	139.43	10.97	215.15
Cash & Short-Term Investments	282.51	255.96	208.19	206.27	236.98	293.6
Cash Growth	-1.36%	22.95%	0.93%	-12.96%	-19.29%	229.30%
Prepaid Expenses	8.61	6.29	4.41	4.18	3.54	3.1
Total Current Assets	291.12	262.25	212.6	210.46	240.52	296.7
Property, Plant & Equipment	2.76	11.3	12.01	14.24	14.21	1.98
Long-Term Investments	45.22	-	26.85	21.95	43.39	-
Other Long-Term Assets	7.76	0.59	0.55	0.53	0.52	0.32
Total Assets	346.86	274.14	252.01	247.18	298.64	299
Accounts Payable	3.13	1.55	0.94	1.32	1.89	0.76
Accrued Expenses	11.65	20.12	16.76	11.41	11.34	7.7
Current Portion of Leases	3.27	3.18	2.75	2.66	1.93	-
Other Current Liabilities	-	-	-	-	-	0.55
Total Current Liabilities	18.05	24.85	20.46	15.39	15.15	9
Long-Term Leases	4.81	6.17	7.46	9.44	10.52	-
Other Long-Term Liabilities	-	-	-	-	-	0.22
Total Liabilities	22.86	31.02	27.92	24.83	25.67	9.22
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	952.95	805.51	658.75	557.87	518.18	456.2
Retained Earnings	-629.15	-562.77	-434.93	-334.23	-245.11	-166.39
Comprehensive Income & Other	0.19	0.38	0.26	-1.29	-0.1	-0.03
Total Common Equity	324	243.12	224.09	222.35	272.98	289.78
Shareholders' Equity	324	243.12	224.09	222.35	272.98	289.78
Total Liabilities & Equity	346.86	274.14	252.01	247.18	298.64	299
Total Debt	8.09	9.36	10.21	12.1	12.44	-
Net Cash (Debt)	274.43	246.6	197.97	194.17	224.54	293.6
Net Cash Growth	-0.81%	24.56%	1.96%	-13.52%	-23.52%	229.30%
Net Cash Per Share	3.78	3.54	3.85	4.90	5.92	13.38
Filing Date Shares Outstanding	97.12	71.03	67.38	45.09	39.43	36.7
Total Common Shares Outstanding	86.19	71.02	54.87	45.09	39.43	36.67
Working Capital	273.07	237.4	192.14	195.07	225.37	287.7
Book Value Per Share	3.76	3.42	4.08	4.93	6.92	7.90
Tangible Book Value	324	243.12	224.09	222.35	272.98	289.78
Tangible Book Value Per Share	3.76	3.42	4.08	4.93	6.92	7.90
Machinery	8.69	8.36	7.39	7.07	5.69	4.76
Leasehold Improvements	2.07	2.04	1.97	1.98	1.71	1.71

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q